- INTRODUCTION TO DEPRESSIVE DISORDERS
- HISTORICAL PERSPECTIVES: MELANCHOLIA TO MODERN DIAGNOSIS
- DSM-5-TR AND ICD-11 CRITERIA FOR DEPRESSIVE DISORDERS
- PHENOMENOLOGY OF DEPRESSION: CORE SYMPTOMS AND VARIANTS
- SUBTYPES OF MAJOR DEPRESSIVE DISORDER (MDD)
- PERSISTENT DEPRESSIVE DISORDER (DYSTHYMIA): CLINICAL OVERVIEW
- DISRUPTIVE MOOD DYSREGULATION DISORDER IN YOUTH
- PREMENSTRUAL DYSPHORIC DISORDER: BIOLOGY AND DIAGNOSIS
- ATYPICAL DEPRESSION AND ITS CLINICAL SIGNIFICANCE
- PSYCHOTIC DEPRESSION AND MOOD-CONGRUENT DELUSIONS
- GLOBAL PREVALENCE AND INCIDENCE OF DEPRESSION
- GENDER DIFFERENCES AND HORMONAL INFLUENCES
- SOCIOECONOMIC DETERMINANTS OF DEPRESSION
- CHILDHOOD TRAUMA AND DEPRESSION RISK
- GENETIC HERITABILITY AND FAMILY STUDIES
- EPIGENETIC MODIFICATIONS IN DEPRESSION
- URBANICITY, MIGRATION, AND DEPRESSION
- IMPACT OF CLIMATE AND SEASONAL VARIATIONS
- CULTURAL PATTERNS AND CROSS-CULTURAL DIAGNOSIS
- PROTECTIVE FACTORS AND RESILIENCE
- NEUROTRANSMITTER HYPOTHESES: SEROTONIN, NOREPINEPHRINE, DOPAMINE
- HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS DYSREGULATION
- NEUROINFLAMMATION AND IMMUNE SYSTEM CONTRIBUTIONS
- BRAIN STRUCTURE CHANGES: HIPPOCAMPUS, AMYGDALA, PREFRONTAL CORTEX
- NEUROPLASTICITY AND SYNAPTIC PRUNING IN DEPRESSION
- BRAIN-DERIVED NEUROTROPHIC FACTOR AND MOOD REGULATION
- MITOCHONDRIAL FUNCTION AND ENERGY METABOLISM
- CIRCADIAN RHYTHM AND SLEEP-WAKE DYSREGULATION
- GUT–BRAIN AXIS AND MICROBIOME IN DEPRESSION
- OXIDATIVE STRESS AND CELLULAR PATHWAYS
- EARLY-ONSET VS. LATE-ONSET DEPRESSION
- RECURRENT VS. SINGLE-EPISODE MAJOR DEPRESSION
- DEPRESSION WITH MIXED FEATURES
- SEASONAL AFFECTIVE DISORDER
- POSTPARTUM DEPRESSION AND PERINATAL MOOD DISORDERS
- DEPRESSION IN ADOLESCENTS AND YOUNG ADULTS
- GERIATRIC DEPRESSION AND COGNITIVE DECLINE
- SOMATIC SYMPTOM PRESENTATIONS OF DEPRESSION
- SUICIDAL IDEATION AND BEHAVIOR IN DEPRESSIVE DISORDERS
- MASKED OR HIDDEN DEPRESSION IN MEDICAL SETTINGS
- ANXIETY–DEPRESSION COMORBIDITY
- SUBSTANCE USE AND DEPRESSIVE DISORDERS
- DEPRESSION AND EATING DISORDERS
- DEPRESSION WITH PERSONALITY DISORDERS
- DEPRESSION IN NEURODEGENERATIVE CONDITIONS
- CARDIOMETABOLIC DISEASE AND DEPRESSION LINKS
- DEPRESSION AND CHRONIC PAIN
- DEPRESSION AND SLEEP DISORDERS
- DEPRESSION AND OBSESSIVE-COMPULSIVE SYMPTOMS
- TRAUMA-RELATED DISORDERS AND DEPRESSION
- CLINICAL INTERVIEWING FOR DEPRESSION
- RATING SCALES: PHQ-9, HAM-D, MADRS
- NEUROCOGNITIVE TESTING IN DEPRESSION
- DIGITAL BIOMARKERS AND WEARABLE TECHNOLOGY
- MACHINE LEARNING FOR DIAGNOSTIC SUPPORT
- DIFFERENTIAL DIAGNOSIS: BIPOLAR VS. UNIPOLAR DEPRESSION
- DISTINGUISHING DEPRESSION FROM GRIEF AND ADJUSTMENT DISORDER
- IDENTIFYING TREATMENT-RESISTANT DEPRESSION EARLY
- LONGITUDINAL MONITORING AND RELAPSE PREDICTION
- ETHICS AND PRIVACY IN DIGITAL DEPRESSION SCREENING
- MECHANISMS OF ANTIDEPRESSANTS: SSRIS, SNRIS
- ATYPICAL ANTIDEPRESSANTS: BUPROPION, MIRTAZAPINE
- TRICYCLICS AND MAO INHIBITORS: HISTORICAL AND CURRENT ROLES
- AUGMENTATION STRATEGIES: LITHIUM, ATYPICAL ANTIPSYCHOTICS
- RAPID-ACTING ANTIDEPRESSANTS: KETAMINE AND ESKETAMINE
- PHARMACOGENOMICS OF ANTIDEPRESSANT RESPONSE
- CHRONOTHERAPY AND MEDICATION TIMING
- MANAGING SIDE EFFECTS AND DRUG INTERACTIONS
- MAINTENANCE THERAPY AND DISCONTINUATION PLANNING
- FUTURE PHARMACOLOGICAL TARGETS: GLUTAMATE, GABA, NEUROPEPTIDES
- COGNITIVE BEHAVIORAL THEORY FOR DEPRESSION
- INTERPERSONAL THERAPY: PRINCIPLES AND EVIDENCE
- BEHAVIORAL ACTIVATION MODELS
- MINDFULNESS-BASED COGNITIVE THERAPY
- ACCEPTANCE AND COMMITMENT THEORY
- PROBLEM-SOLVING THERAPY
- GROUP PSYCHOEDUCATION AND SUPPORT MODELS
- ONLINE AND DIGITAL PSYCHOTHERAPY PLATFORMS
- FAMILY-FOCUSED PSYCHOEDUCATION IN DEPRESSION
- SOCIAL PRESCRIBING AND COMMUNITY ENGAGEMENT CONCEPTS
- GLOBAL BURDEN OF DEPRESSIVE DISORDERS
- HEALTH ECONOMICS OF DEPRESSION TREATMENT
- MENTAL HEALTH POLICY AND RESOURCE ALLOCATION
- WORKPLACE MENTAL HEALTH AND DEPRESSION
- SCHOOL-BASED DEPRESSION PREVENTION PROGRAMS
- REDUCING STIGMA AND IMPROVING HELP-SEEKING
- SUICIDE PREVENTION POLICY AND ETHICS
- INTEGRATING DEPRESSION CARE IN PRIMARY CARE SETTINGS
- MENTAL HEALTH LEGISLATION AND PATIENTS’ RIGHTS
- PUBLIC CAMPAIGNS FOR EARLY DETECTION
- PRECISION PSYCHIATRY IN DEPRESSIVE DISORDERS
- BIOMARKERS OF TREATMENT RESPONSE
- NEUROIMAGING AS A PREDICTIVE TOOL
- EPIGENETIC EDITING AND GENE THERAPY CONCEPTS
- PSYCHEDELIC RESEARCH FOR DEPRESSION
- ARTIFICIAL INTELLIGENCE IN TREATMENT SELECTION
- LONGITUDINAL BIG-DATA COHORTS IN DEPRESSION
- CLIMATE CHANGE AND FUTURE DEPRESSION TRENDS
- ETHICAL ISSUES IN NOVEL ANTIDEPRESSANT DEVELOPMENT
- GLOBAL COLLABORATION TO END THE DEPRESSION TREATMENT GAP